Quotient (NASDAQ: QTNT)
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-04 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.310 | -0.250 | 0.0600 | ||||
REV | 8.170M | 9.786M | 1.616M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Quotient (NASDAQ: QTNT) through any online brokerage.
Other companies in Quotient’s space includes: Pulmonx (NASDAQ:LUNG), RxSight (NASDAQ:RXST), TELA Bio (NASDAQ:TELA), Chembio Diagnostics (NASDAQ:CEMI) and Predictive Oncology (NASDAQ:POAI).
The latest price target for Quotient (NASDAQ: QTNT) was reported by Cowen & Co. on Wednesday, June 29, 2022. The analyst firm set a price target for 3.00 expecting QTNT to rise to within 12 months (a possible 1112.12% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Quotient (NASDAQ: QTNT) is $0.2475 last updated June 29, 2022, 8:00 PM UTC.
There are no upcoming dividends for Quotient.
Quotient’s Q1 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Quotient.
Quotient is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.